120017
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.6 Breast Cancer (Dove Med Press)
- 4.3 Clin Epidemiol
- 2.6 Cancer Manag Res
- 3.2 Infect Drug Resist
- 4.1 Clin Interv Aging
- 6.1 Drug Des Dev Ther
- 4.1 Int J Chronic Obstr
- 8.7 Int J Nanomed
- 2.5 Int J Women's Health
- 3.2 Neuropsych Dis Treat
- 2.4 OncoTargets Ther
- 2.6 Patient Prefer Adher
- 2.6 Ther Clin Risk Manag
- 3.1 J Pain Res
- 3.5 Diabet Metab Synd Ob
- 4.5 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 2.4 Pharmgenomics Pers Med
- 2.6 Risk Manag Healthc Policy
- 4.6 J Inflamm Res
- 2.3 Int J Gen Med
- 3.9 J Hepatocell Carcinoma
- 3.3 J Asthma Allergy
- 2.5 Clin Cosmet Investig Dermatol
- 3.0 J Multidiscip Healthc
已发表论文
2020—2024年中国西南地区儿童尿路感染病原菌分布及耐药性变化
Authors You Z , Huang X, Liu X, Yu H, Long S
Received 13 November 2025
Accepted for publication 16 January 2026
Published 24 January 2026 Volume 2026:19 581416
DOI https://doi.org/10.2147/IDR.S581416
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
Editor who approved publication: Dr Hazrat Bilal
Zhuorui You,1 Xiangning Huang,2 Xin Liu,2 Hua Yu,2 Shanshan Long2
1School of Medicine, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China; 2Department of Laboratory Medicine, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, People’s Republic of China
Correspondence: Shanshan Long, Email longss423@163.com Hua Yu, Email yvhua2002@163.com
Objective: Urinary tract infection (UTI) is a major health concern in pediatric populations. By analysing temporal changes in pathogen distribution and antimicrobial resistance among children with UTIs in Southwest China from 2020 to 2024, we aim to provide a robust scientific basis for the empirical antibiotic therapy in this region.
Methods: We retrospectively analyzed non-duplicate pathogens isolated from urine specimens and their antimicrobial susceptibility results in 6598 children (≤ 14 years old) diagnosed with UTIs in southwest China from 2020 to 2024. These results were interpreted according to the M100 guidelines of the American Clinical and Laboratory Standards Institute (CLSI) and analysed using WHONET 5.6 software.
Results: A total of 7831 strains of pathogenic bacteria were detected, of which 60.1% were gram-negative and 39.9% were gram-positive. The top five bacteria detected were Escherichia coli (37.8%), Enterococcus faecium (26.3%), Enterococcus faecalis (7.5%), Klebsiella pneumoniae (6.9%) and Pseudomonas aeruginosa (2.5%). E. coli showed less than 10% resistance to piperacillin/tazobactam, cefoperazone/sulbactam, amikacin and nitrofurantoin, with resistance to quinolones ranging from 31.3% to 51.5%. K. pneumoniae showed resistance rates of 13.1% and 16.8% to imipenem and meropenem, respectively, from 2020 to 2024. E. faecium showed significantly higher resistance rates to the tested drugs than E. faecalis, particularly to ampicillin (95.1– 97.4% vs 4.9– 8.0%). Methicillin-resistant Staphylococcus aureus (MRSA) was detected at a rate of 33.8%. MRSA showed a higher level of resistance to penicillin, rifampicin, levofloxacin, clindamycin and erythromycin than methicillin-sensitive strains.
Conclusion: Over the past five years, the main pathogenic bacteria responsible for pediatric UTIs in southwestern China were E. coli, E. faecium and E. faecalis. Resistance patterns among major uropathogens revealed diverse trends, and the emergence of multidrug-resistant organisms presents a serious therapeutic challenge that warrants close surveillance.
Keywords: urinary tract infection, drug resistance, children, China, surveillance of drug resistance
1School of Medicine, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China; 2Department of Laboratory Medicine, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, People’s Republic of China
Correspondence: Shanshan Long, Email longss423@163.com Hua Yu, Email yvhua2002@163.com
Objective: Urinary tract infection (UTI) is a major health concern in pediatric populations. By analysing temporal changes in pathogen distribution and antimicrobial resistance among children with UTIs in Southwest China from 2020 to 2024, we aim to provide a robust scientific basis for the empirical antibiotic therapy in this region.
Methods: We retrospectively analyzed non-duplicate pathogens isolated from urine specimens and their antimicrobial susceptibility results in 6598 children (≤ 14 years old) diagnosed with UTIs in southwest China from 2020 to 2024. These results were interpreted according to the M100 guidelines of the American Clinical and Laboratory Standards Institute (CLSI) and analysed using WHONET 5.6 software.
Results: A total of 7831 strains of pathogenic bacteria were detected, of which 60.1% were gram-negative and 39.9% were gram-positive. The top five bacteria detected were Escherichia coli (37.8%), Enterococcus faecium (26.3%), Enterococcus faecalis (7.5%), Klebsiella pneumoniae (6.9%) and Pseudomonas aeruginosa (2.5%). E. coli showed less than 10% resistance to piperacillin/tazobactam, cefoperazone/sulbactam, amikacin and nitrofurantoin, with resistance to quinolones ranging from 31.3% to 51.5%. K. pneumoniae showed resistance rates of 13.1% and 16.8% to imipenem and meropenem, respectively, from 2020 to 2024. E. faecium showed significantly higher resistance rates to the tested drugs than E. faecalis, particularly to ampicillin (95.1– 97.4% vs 4.9– 8.0%). Methicillin-resistant Staphylococcus aureus (MRSA) was detected at a rate of 33.8%. MRSA showed a higher level of resistance to penicillin, rifampicin, levofloxacin, clindamycin and erythromycin than methicillin-sensitive strains.
Conclusion: Over the past five years, the main pathogenic bacteria responsible for pediatric UTIs in southwestern China were E. coli, E. faecium and E. faecalis. Resistance patterns among major uropathogens revealed diverse trends, and the emergence of multidrug-resistant organisms presents a serious therapeutic challenge that warrants close surveillance.
Keywords: urinary tract infection, drug resistance, children, China, surveillance of drug resistance